Fighting Ebola with ZMapp: spotlight on plant-made antibody

被引：0
|
作者：
ZHANG YunFang [1 ]
LI DaPeng [1 ]
JIN Xia [1 ]
HUANG Zhong [1 ]
机构：
[1] Vaccine Research Center, Institut Pasteur of Shanghai, Chinese Academy of Sciences
来源：
Science China(Life Sciences) | 2014年 / 10期
关键词：
spotlight on plant-made antibody; Fighting Ebola with ZMapp;
D O I：
暂无
中图分类号：
R373.3 [节肢动物传播的病毒（虫媒病毒）];
学科分类号：
摘要：
Currently,a large Ebola endemic is ongoing in West Africa.According to the World Health Organization,as of August19,the viral outbreak has led to 2240 suspected and confirmed cases and 1229 deaths in four countries:Guinea,Liberia,Nigeria,and Sierra Leone(http://www.cdc.gov/vhf/ebola/outbreaks/guinea/index.html).
引用
收藏
页码：987 / 988
页数：2
相关论文
共 50 条
  • [41] Regulatory issues for plant-made pharmaceuticals and vaccines
    Streatfield, SJ
    EXPERT REVIEW OF VACCINES, 2005, 4 (04) : 591 - 601
  • [42] Plant-made pharmaceuticals: Where are we now?
    Bethell, D. R.
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2005, 41 : 2A - 2A
  • [43] Research advances in plant-made flavivirus antigens
    Martinez, C. A.
    Giulietti, A. M.
    Rodriguez Talou, J.
    BIOTECHNOLOGY ADVANCES, 2012, 30 (06) : 1493 - 1505
  • [44] Antibody-Dependent Enhancement Activity of a Plant-Made Vaccine against West Nile Virus
    Sun, Haiyan
    Acharya, Dhiraj
    Paul, Amber M.
    Lai, Huafang
    He, Junyun
    Bai, Fengwei
    Chen, Qiang
    VACCINES, 2023, 11 (02)
  • [45] Plant-made immunotoxin building blocks: A roadmap for producing therapeutic antibody-toxin fusions
    Knoedler, M.
    Buyel, J. F.
    BIOTECHNOLOGY ADVANCES, 2021, 47
  • [46] Current status of plant-made vaccines for veterinary purposes
    Ling, Huai-Yian
    Pelosi, Assunta
    Walmsley, Amanda M.
    EXPERT REVIEW OF VACCINES, 2010, 9 (08) : 971 - 982
  • [47] Oral immunogenicity of a plant-made, subunit, tuberculosis vaccine
    Rigano, MM
    Dreitz, S
    Kipnis, AP
    Izzo, AA
    Walmsley, AM
    VACCINE, 2006, 24 (05) : 691 - 695
  • [48] Plant-made vaccines and reagents for the One Health initiative
    Rybicki, Edward Peter
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (12) : 2912 - 2917
  • [49] US regulation of plant-made biopharmaceuticals - Part 1
    Berberich, SA
    Devine, RA
    BIOPHARM INTERNATIONAL, 2005, 18 (01) : 38 - +
  • [50] Implementation of Glycan Remodeling to Plant-Made Therapeutic Antibodies
    Bennett, Lindsay D.
    Yang, Qiang
    Berquist, Brian R.
    Giddens, John P.
    Ren, Zhongjie
    Kommineni, Vally
    Murray, Ryan P.
    White, Earl L.
    Holtz, Barry R.
    Wang, Lai-Xi
    Marcel, Sylvain
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (02)
12345